Last reviewed · How we verify
NCT04699903
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood
trial testing POC SARS-Cov-2 IgG Antibody test in SARS-Cov-2, Covid19 in 201 participants. Completed in 9 April 2021.
29 January 2021
Quick facts
| Lead sponsor | Lumos Diagnostics |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 201 |
| Start date | 5 January 2021 |
| Primary completion | 29 January 2021 |
| Estimated completion | 9 April 2021 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- POC SARS-Cov-2 IgG Antibody test
Conditions studied
- SARS-Cov-2, Covid19 — all drugs for SARS-Cov-2, Covid19 →
Sponsor
Lumos Diagnostics
Who can join
1 and older, any sex, with SARS-Cov-2, Covid19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective, multi-center, observational, blinded clinical trial to compare a new point of care (POC) SARS-CoV-2 IgG antibody test to a reference SARS-CoV-2 PCR test using fingerstick whole blood.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04699903
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Lumos Diagnostics trials
Trials by the same sponsor.
- NCT07211997 — FebriDx® Pediatric Validation Study · recruiting
- NCT06746259 — FebriDx® Method Comparison Study Protocol · completed
- NCT05998109 — PheCheck Feasibility Study · completed
- NCT05403346 — Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™) · terminated
- NCT04750629 — Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04699903 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lumos Diagnostics
- Last refreshed: 18 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04699903.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing